The ARC Training Centre for Biopharmaceutical Innovation (CBI)

The CBI combines the research and development, and manufacturing expertise and capabilities of the industry partners and The University of Queensland (UQ). Industry-driven research projects ensures industry-ready graduates drive growth in the sector. The CBI housed within the Australian institute for Bioengineering and Nanotechnology (AIBN) at UQ and collaborates with the National Biologics Facility, also housed within the AIBN.

Discovery of new biopharmaceuticals and mAb based reagents utilising innovative methodologies in therapeutic and diagnostic mAb discovery, as well as the development of platform technologies for mAb delivery to intracellular targets.

We are working on understanding cellular bottlenecks for production of therapeutic proteins and bypass those bottlenecks by modifying relevant cellular pathways, and engineering the therapeutic proteins for improved expression.

Large-scale cell culture and downstream processing represent the greatest driver of cost of goods for biopharmaceuticals. We are working on process improvements to provide gains in product quality, yield and characterisation.

News

Our CBI staff hosted a Science Extravaganza event at the Chapel Hill State School as part of the school’s Science Week program. The students witnessed the exciting and innovative ways in which science exists in our lives. We indulged them in some fun and enriching activities to stimulate their interest in science and engineering. The […]

The ARC Training Centre for Biopharmaceutical Innovation is multi-million dollar Australian Government initiative under the Australian Research Council Industrial Transformation Research Programme.